Work

Abstract PS2-02-15: The impact of ASCO/CCO guidelines on the use of adjuvant bone-modifying agents by specialized and general oncologists for elderly patients with breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-02-15

Authors: N. Dalal, H. Tang, M. Reitsma, J. Dickerson, S. Phillips, B. Staiger, J. Goldhaber-Fiebert, J. Caswell-Jin

Institutions: Stanford Medicine, Stanford University, University of California, Berkeley

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129495937

Cites:

Cited by:

Related to: